Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 73

Sort by

Sort Order Select

Journal Articles

Potential biomarkers and mechanisms in central nervous system involvement of KMT2A rearranged b-ALL: Insights from Patient-derived xenograft models

Der-Shiun Wang, Jhih-Yu Pan, Yu-Chun Liao, Chia-Lun Hong, Chih- Hsiang Yu, Ying-Hui Su, Huei-Ying Li, Shu-Wei Chou, Meng-Yao Lu, Hsiu-Hao Chang, Shiann-Tang Jou, Wen-Chien Chou, Yung-Li Yang, Shu-Wha Lin

Blood (2025) 146 (Supplement 1): 3256.

https://doi.org/10.1182/blood-2025-3256

Published: 2025

Journal Articles

Rapid, efficient and durable fetal hemoglobin production following CS-101 treatment in transfusion-dependent β-thalassemia participants: An autologous, ex vivo edited CD34+ stem cell product using the innovative transformer base editor (tBE)

Jia Chen, Yongrong Lai, Xiaowen Zhai, Wei Li Zhao, Rongrong Liu, Xiaowen Qian, Wei Tang, Lijie Wang, Xu-Kai Ma, Yaliang Li, Jia Wei, Kewei Lan, Yan Zhang, Li Yang, Xiaodun (Susan) Mou

Blood (2025) 146 (Supplement 1): 6090.

https://doi.org/10.1182/blood-2025-6090

Published: 2025

Journal Articles

Aponermin combined with carfilzomid-pomalidomide-dexamethasone (KPd) in patients with relapsed or refractory multiple myeloma: A prospective, open-label, multicenter study

Jing Chen, Donghua He, Xiaoyan Han, Mingming Zhang, Li Yang, Haimeng Yan, Lai Jin, He Huang, Juan Du, Aijun Liu, Zhen Cai

Blood (2025) 146 (Supplement 1): 2276.

https://doi.org/10.1182/blood-2025-2276

Published: 2025

Journal Articles

Prognostic significance of 1q21 gain/amplification and co-existing cytogenetic abnormalities in Chinese patients with newly diagnosed multiple myeloma

Xinyuan Dai, YI LI, Gaofeng Zheng, Xiaoyan Han, Minlei Zhao, Yang Yang, Donghua He, Li Yang, Dan Cao, Lihong Shou, Linjie Li, Haowen Xiao, Wenjun Wu, Yi Zhao, Zhen Cai, Jingsong He

Blood (2025) 146 (Supplement 1): 2242.

https://doi.org/10.1182/blood-2025-2242

Published: 2025

Journal Articles

A real world study of inotuzumab ozogamicin for the treatment of B-cell acute lymphoblastic leukemia: Multi-center result from SH-ALL group

Yuchen Yan, Ligen Liu, Jie Hao, Xiaofeng Han, Ping Li, Libing Wang, Li Yang, Yong Tang, Cheng Wang, Weiyang Liu, Jiayi Ren, Jiong Hu, Jianmin Yang, Qi Zhu, Aibin Liang, Jian Hou, Xianmin Song, Jianqing Mi, JIN WANG

Blood (2025) 146 (Supplement 1): 6830.

https://doi.org/10.1182/blood-2025-6830

Published: 2025

Journal Articles

Calcineurin inhibitors reduce risk of MGUS progression to multiple myeloma in immunosuppressant users: A retrospective multi-institution cohort study

Li-Yang Shiau, Chien-Yun Chen, Hao-Yuan Wang, Hung-Cheng Tsai, Sunny Ssu-Yu Chen, Tina Ting-An Lin, Yi-Lin Chiang, Po-Shen Ko

Blood (2025) 146 (Supplement 1): 3959.

https://doi.org/10.1182/blood-2025-3959

Published: 2025

Journal Articles

Selinexor in combination with venetoclax and azacitidine for newly diagnosed (ND) unfit Acute Myeloid Leukemia (AML): A multicenter, open-label prospective study

Ligen Liu, Li Yang, Fangli Chen, Li Chang, Limin Zhao, Xiang Zhou, Chunrong Ying, Yingting Lu, Hong Liang, Yuansong Bai, Wenzhong Wu, Xiaojing Yan, Jinhai Ren, Si Li, Yang Yu, Laigen Tong, Deng Pan

Blood (2025) 146 (Supplement 1): 1685.

https://doi.org/10.1182/blood-2025-1685

Published: 2025

Journal Articles

Characteristics of immune genes rearrangements in Chinese multiple myeloma patients

Donghua He, Yang Yang, Yiwei Zhou, Enfan Zhang, Li Yang, Xiaoyan Han, Jingsong He, Zhen Cai

Blood (2025) 146 (Supplement 1): 5759.

https://doi.org/10.1182/blood-2025-5759

Published: 2025

Journal Articles

Anomalous Peaks Observed in the Mass Spectrometry of Light Chains Correlate with the Diagnosis of AL Amyloidosis

Mengmeng Dong, Xiao Xiao, Zhen Cai, Jiasheng Wang, Yang Yang, Gaofeng Zheng, Li Yang, Haimeng Yan

Blood (2024) 144 (Supplement 1): 6894.

https://doi.org/10.1182/blood-2024-210534

Published: 2024

Journal Articles

Safety and Efficacy of R-PAD Regimen in Patients with Severe Multiple Center Idiopathic Castleman Disease: A Retrospective Case Series

Yingting Lu, Chunrong Ying, Ligen Liu, Limin Zhao, Xuewei Jiang, Tinghua Zhang, Zhizhi Zhang, Xiang Zhou, Li Chang, Xinying Zhu, Chao Du, Li Yang

Blood (2024) 144 (Supplement 1): 6888.

https://doi.org/10.1182/blood-2024-207982

Published: 2024

Journal Articles

Safety and Efficacy of Ivosidenib Based Regimen in Patients with IDH1 Mutanted Acute Myeloid Leukemia: A Retrospective Case Series

Limin Zhao, Ligen Liu, Li Yang, Fangli Chen, Xuewei Jiang, Tinghua Zhang, Zhizhi Zhang, Xiang Zhou, Li Chang, Xinying Zhu, Chao Du, Chunrong Ying

Blood (2024) 144 (Supplement 1): 6055.

https://doi.org/10.1182/blood-2024-207516

Published: 2024

Journal Articles

Mastl Is a New Therapeutic Target for Acute Myeloid Leukemia

Fangli Chen, Ligen Liu, Huijie Chen, Yicheng Wu, Yuanqin Wang, Zhen Fu, Tinghua Zhang, Xuewei Jiang, Yingting Lu, Limin Zhao, Jutang Li, Li Yang

Blood (2024) 144 (Supplement 1): 5842.

https://doi.org/10.1182/blood-2024-207505

Published: 2024

Journal Articles

Selinexor Combined with Daratumumab, Thalidomide, and Dexamethasone in Patients with First Relapsed Multiple Myeloma: A Single-Arm, Multicenter, Prospective Study

Qingxiao Chen, Jiasheng Wang, Yang Yang, Gaofeng Zheng, Jing Chen, Xiaoyan Han, Li Yang, Wenjun Wu, YI LI, Donghua He, Jingsong He, Zhen Cai

Blood (2024) 144 (Supplement 1): 7051.

https://doi.org/10.1182/blood-2024-197887

Published: 2024

Journal Articles

Validating Low Flow Cytometry Events with Next-Generation Sequencing for Precise Detection of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia

Shu-Wei Chou, Meng-Yao Lu, Yung-Li Yang, Hsiu-Hao Chang, Xavier Cheng-Hong Tsai, Chia-Jui Du, Shiann-Tarng Jou

Blood (2024) 144 (Supplement 1): 2839.

https://doi.org/10.1182/blood-2024-203037

Published: 2024

Journal Articles

Rapid, Efficient and Durable Fetal Hemoglobin Production Following CS-101 Treatment in Transfusion-Dependent β-Thalassemia Participants: An Autologous, Ex Vivo Edited CD34+ Stem Cell Product Using the Innovative Transformer Base Editor (tBE)

Yongrong Lai, Rongrong Liu, Lijie Wang, Xu-Kai Ma, Yaliang Li, Gaohui Yang, Lingling Shi, Jia Wei, Zhenbin Wei, Xuemei Zhou, Kewei Lan, Yan Zhang, Xiaodun (Susan) Mou, Li Yang, Jia Chen

Blood (2024) 144 (Supplement 1): 4962.

https://doi.org/10.1182/blood-2024-200691

Published: 2024

Journal Articles

Characteristics and Long-Term Efficacy of 25 Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab or Ravulizumab in Taiwan

Hsing-Yu Lin, Yu-Wen Chen, Ta-Chuan Yu, Feng-Ming Tien, Chien-Chin Lin, Sheng-Chieh Chou, Shang-Ju Wu, Bor-Sheng Ko, Yung-Li Yang, Ming Yao, Woei Tsay, Hwei-Fang Tien, Hsin-An Hou, Wen-Chien Chou

Blood (2024) 144 (Supplement 1): 5672.

https://doi.org/10.1182/blood-2024-199918

Published: 2024

Journal Articles

Innovative Transformer Base Editor (tBE)-Mediated Editing at BCL11A Binding Motif Triggers High Level of γ-Globin Expression with No Observable Off-Target Mutations

Jia Chen, Wenyan Han, Hou-Yuan Qiu, Shangwu Sun, Zhi-Can Fu, Guo-Quan Wang, Li Yang, Bei Yang, Ying Zhang

Blood (2023) 142 (Supplement 1): 7125.

https://doi.org/10.1182/blood-2023-178277

Published: 2023

Journal Articles

Venetoclax Combined with Azacitidine Was Effective and Safe for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma: Preliminary Results of a Phase 2, Multicenter Trial

Han-Yu Cao, Lu-Lu Chen, Chao-Ling Wan, Xiao-Hui Hu, Bing Wu, Li Yang, Li Wang, Yang Zhang, De-Pei Wu, Hai-Ping Dai, Hao Zhang, Shengli Xue

Blood (2023) 142 (Supplement 1): 1501.

https://doi.org/10.1182/blood-2023-179733

Published: 2023

Journal Articles

Increase of Dnts Correlated with Clinic Outcome after Allogeneic DNT Cells Infusion in r/r AML Patients

Huiyao Gu, Donghua He, Xiaofeng Han, Yi Li, Li Yang, Enfan Zhang, Haicun Xie, Yu Cheng, Fuqiang Wu, Guangrong Song, Daqing Liu, Liming Yang, Jingsong He, Zhen Cai

Blood (2023) 142 (Supplement 1): 6867.

https://doi.org/10.1182/blood-2023-186221

Published: 2023

Journal Articles

Selinexor in Combination with Venetoclax and Azacitidine for Newly Diagnosed (ND) Unfit Acute Myeloid Leukemia (AML): A Multicenter, Open-Label Prospective Study

Li Yang, Fangli Chen, Hong Liang, Yunsong Bai, Wenzhong Wu, Xiaojing Yan, Jinhai Ren, Si Li, Yang Yu, Laigen Tong, Deng Pan, Ligen Liu

Blood (2023) 142 (Supplement 1): 55.

https://doi.org/10.1182/blood-2023-184581

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Potential biomarkers and mechanisms in central nervous system involvement of KMT2A rearranged b-ALL: Insights from Patient-derived xenograft models

Rapid, efficient and durable fetal hemoglobin production following CS-101 treatment in transfusion-dependent β-thalassemia participants: An autologous, ex vivo edited CD34+ stem cell product using the innovative transformer base editor (tBE)

Aponermin combined with carfilzomid-pomalidomide-dexamethasone (KPd) in patients with relapsed or refractory multiple myeloma: A prospective, open-label, multicenter study

Prognostic significance of 1q21 gain/amplification and co-existing cytogenetic abnormalities in Chinese patients with newly diagnosed multiple myeloma

A real world study of inotuzumab ozogamicin for the treatment of B-cell acute lymphoblastic leukemia: Multi-center result from SH-ALL group

Calcineurin inhibitors reduce risk of MGUS progression to multiple myeloma in immunosuppressant users: A retrospective multi-institution cohort study

Selinexor in combination with venetoclax and azacitidine for newly diagnosed (ND) unfit Acute Myeloid Leukemia (AML): A multicenter, open-label prospective study

Characteristics of immune genes rearrangements in Chinese multiple myeloma patients

Anomalous Peaks Observed in the Mass Spectrometry of Light Chains Correlate with the Diagnosis of AL Amyloidosis

Safety and Efficacy of R-PAD Regimen in Patients with Severe Multiple Center Idiopathic Castleman Disease: A Retrospective Case Series

Safety and Efficacy of Ivosidenib Based Regimen in Patients with IDH1 Mutanted Acute Myeloid Leukemia: A Retrospective Case Series

Mastl Is a New Therapeutic Target for Acute Myeloid Leukemia

Selinexor Combined with Daratumumab, Thalidomide, and Dexamethasone in Patients with First Relapsed Multiple Myeloma: A Single-Arm, Multicenter, Prospective Study

Validating Low Flow Cytometry Events with Next-Generation Sequencing for Precise Detection of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia

Rapid, Efficient and Durable Fetal Hemoglobin Production Following CS-101 Treatment in Transfusion-Dependent β-Thalassemia Participants: An Autologous, Ex Vivo Edited CD34+ Stem Cell Product Using the Innovative Transformer Base Editor (tBE)

Characteristics and Long-Term Efficacy of 25 Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab or Ravulizumab in Taiwan

Innovative Transformer Base Editor (tBE)-Mediated Editing at BCL11A Binding Motif Triggers High Level of γ-Globin Expression with No Observable Off-Target Mutations

Venetoclax Combined with Azacitidine Was Effective and Safe for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma: Preliminary Results of a Phase 2, Multicenter Trial

Increase of Dnts Correlated with Clinic Outcome after Allogeneic DNT Cells Infusion in r/r AML Patients

Selinexor in Combination with Venetoclax and Azacitidine for Newly Diagnosed (ND) Unfit Acute Myeloid Leukemia (AML): A Multicenter, Open-Label Prospective Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only